Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs Franklin Resources, Inc. (BEN) Price & Performance

Adaptive Biotechnologies CorpTrade
Franklin Resources, Inc.Trade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs Franklin Resources, Inc. — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Franklin Resources, Inc. trades at $33.37 (market cap $16.95B). The key difference: Franklin Resources, Inc. is far larger — about 4.2× Adaptive Biotechnologies Corp's market cap, and Franklin Resources, Inc. pays a 3.96% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTBEN
Market Cap
$4.04B$16.95B
Sector
HealthFinancials
52-Week High
$25.45$35.77
52-Week Low
$12.30$21.18
Enterprise Value
$4.10B$29.90B
Dividend Yield
3.96%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About Franklin Resources, Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.

Read more on BEN